Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma

Alan R. Penheiter, Sibel Erdogan, Stephen J. Murphy, Steven Hart, Joema Felipe Lima, Fariborz Rakhshan Rohakhtar, Daniel R. O'Brien, William R. Bamlet, Ryan E. Wuertz, Thomas Christopher Smyrk, Fergus J Couch, George Vasmatzis, Claire E. Bender, Stephanie K Carlson

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

We used a target-centric strategy to identify transporter proteins upregulated in pancreatic ductal adenocarcinoma (PDAC) as potential targets for a functional imaging probe to complement existing anatomical imaging approaches. We performed transcriptomic profiling (microarray and RNASeq) on histologically confirmed primary PDAC tumors and normal pancreas tissue from 33 patients, including five patients whose tumors were not visible on computed tomography. Target expression was confirmed with immunohistochemistry on tissue microarrays from 94 PDAC patients. The best imaging target identified was SLC6A14 (a neutral and basic amino acid transporter). SLC6A14 was overexpressed at the transcriptional level in all patients and expressed at the protein level in 95% of PDAC tumors. Very little is known about the role of SLC6A14 in PDAC and our results demonstrate that this target merits further investigation as a candidate transporter for functional imaging of PDAC.

Original languageEnglish (US)
Article number593572
JournalBioMed Research International
Volume2015
DOIs
StatePublished - 2015

Fingerprint

Adenocarcinoma
Imaging techniques
Tumors
Microarrays
Tissue
Neutral Amino Acids
Amino Acid Transport Systems
Basic Amino Acids
Neutral Amino Acid Transport Systems
Tomography
Neoplasms
Proteins
Pancreas
Immunohistochemistry

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma. / Penheiter, Alan R.; Erdogan, Sibel; Murphy, Stephen J.; Hart, Steven; Felipe Lima, Joema; Rakhshan Rohakhtar, Fariborz; O'Brien, Daniel R.; Bamlet, William R.; Wuertz, Ryan E.; Smyrk, Thomas Christopher; Couch, Fergus J; Vasmatzis, George; Bender, Claire E.; Carlson, Stephanie K.

In: BioMed Research International, Vol. 2015, 593572, 2015.

Research output: Contribution to journalArticle

Penheiter, AR, Erdogan, S, Murphy, SJ, Hart, S, Felipe Lima, J, Rakhshan Rohakhtar, F, O'Brien, DR, Bamlet, WR, Wuertz, RE, Smyrk, TC, Couch, FJ, Vasmatzis, G, Bender, CE & Carlson, SK 2015, 'Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma', BioMed Research International, vol. 2015, 593572. https://doi.org/10.1155/2015/593572
Penheiter, Alan R. ; Erdogan, Sibel ; Murphy, Stephen J. ; Hart, Steven ; Felipe Lima, Joema ; Rakhshan Rohakhtar, Fariborz ; O'Brien, Daniel R. ; Bamlet, William R. ; Wuertz, Ryan E. ; Smyrk, Thomas Christopher ; Couch, Fergus J ; Vasmatzis, George ; Bender, Claire E. ; Carlson, Stephanie K. / Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma. In: BioMed Research International. 2015 ; Vol. 2015.
@article{1936bb0589c148c8af9df1ddfbacacca,
title = "Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma",
abstract = "We used a target-centric strategy to identify transporter proteins upregulated in pancreatic ductal adenocarcinoma (PDAC) as potential targets for a functional imaging probe to complement existing anatomical imaging approaches. We performed transcriptomic profiling (microarray and RNASeq) on histologically confirmed primary PDAC tumors and normal pancreas tissue from 33 patients, including five patients whose tumors were not visible on computed tomography. Target expression was confirmed with immunohistochemistry on tissue microarrays from 94 PDAC patients. The best imaging target identified was SLC6A14 (a neutral and basic amino acid transporter). SLC6A14 was overexpressed at the transcriptional level in all patients and expressed at the protein level in 95{\%} of PDAC tumors. Very little is known about the role of SLC6A14 in PDAC and our results demonstrate that this target merits further investigation as a candidate transporter for functional imaging of PDAC.",
author = "Penheiter, {Alan R.} and Sibel Erdogan and Murphy, {Stephen J.} and Steven Hart and {Felipe Lima}, Joema and {Rakhshan Rohakhtar}, Fariborz and O'Brien, {Daniel R.} and Bamlet, {William R.} and Wuertz, {Ryan E.} and Smyrk, {Thomas Christopher} and Couch, {Fergus J} and George Vasmatzis and Bender, {Claire E.} and Carlson, {Stephanie K}",
year = "2015",
doi = "10.1155/2015/593572",
language = "English (US)",
volume = "2015",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma

AU - Penheiter, Alan R.

AU - Erdogan, Sibel

AU - Murphy, Stephen J.

AU - Hart, Steven

AU - Felipe Lima, Joema

AU - Rakhshan Rohakhtar, Fariborz

AU - O'Brien, Daniel R.

AU - Bamlet, William R.

AU - Wuertz, Ryan E.

AU - Smyrk, Thomas Christopher

AU - Couch, Fergus J

AU - Vasmatzis, George

AU - Bender, Claire E.

AU - Carlson, Stephanie K

PY - 2015

Y1 - 2015

N2 - We used a target-centric strategy to identify transporter proteins upregulated in pancreatic ductal adenocarcinoma (PDAC) as potential targets for a functional imaging probe to complement existing anatomical imaging approaches. We performed transcriptomic profiling (microarray and RNASeq) on histologically confirmed primary PDAC tumors and normal pancreas tissue from 33 patients, including five patients whose tumors were not visible on computed tomography. Target expression was confirmed with immunohistochemistry on tissue microarrays from 94 PDAC patients. The best imaging target identified was SLC6A14 (a neutral and basic amino acid transporter). SLC6A14 was overexpressed at the transcriptional level in all patients and expressed at the protein level in 95% of PDAC tumors. Very little is known about the role of SLC6A14 in PDAC and our results demonstrate that this target merits further investigation as a candidate transporter for functional imaging of PDAC.

AB - We used a target-centric strategy to identify transporter proteins upregulated in pancreatic ductal adenocarcinoma (PDAC) as potential targets for a functional imaging probe to complement existing anatomical imaging approaches. We performed transcriptomic profiling (microarray and RNASeq) on histologically confirmed primary PDAC tumors and normal pancreas tissue from 33 patients, including five patients whose tumors were not visible on computed tomography. Target expression was confirmed with immunohistochemistry on tissue microarrays from 94 PDAC patients. The best imaging target identified was SLC6A14 (a neutral and basic amino acid transporter). SLC6A14 was overexpressed at the transcriptional level in all patients and expressed at the protein level in 95% of PDAC tumors. Very little is known about the role of SLC6A14 in PDAC and our results demonstrate that this target merits further investigation as a candidate transporter for functional imaging of PDAC.

UR - http://www.scopus.com/inward/record.url?scp=84935907419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84935907419&partnerID=8YFLogxK

U2 - 10.1155/2015/593572

DO - 10.1155/2015/593572

M3 - Article

C2 - 26106611

AN - SCOPUS:84935907419

VL - 2015

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 593572

ER -